Ibuprofen; Uses, Dosage, Side Effects, Interactions Ibuprofen is a nonsteroidal anti-inflammatory agent with analgesic properties used in the therapy of rheumatism and arthritis. Ibuprofen is a propionic acid derivate and nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic effects. Ibuprofen inhibits the activity of cyclo-oxygenase I and II, resulting in a decreased formation of precursors of prostaglandins and thromboxanes. This leads to decreased prostaglandin synthesis, by prostaglandin synthase, the main physiologic effect of ibuprofen. Ibuprofen also causes a decrease in the formation of thromboxane A2 synthesis, by thromboxane synthase, thereby inhibiting platelet aggregation. (NCI05) Ibuprofen is a commonly used nonsteroidal anti-inflammatory (NSAID) drug which is available both by prescription and over-the-counter. Ibuprofen is considered to be among the safest NSAIDs and is generally well tolerated but can, nevertheless, rarely cause clinically apparent and serious acute liver injury. Mechanism of Action of Ibuprofen The exact mechanism of action of ibuprofen is unknown. Ibuprofen is a non-selective inhibitor of cyclooxygenase, an enzyme involved in prostaglandin synthesis via the arachidonic acid pathway. Its pharmacological effects are believed to be due to inhibition cyclooxygenase-2 (COX-2) which decrease the synthesis of prostaglandins involved in mediating inflammation, pain, fever, and swelling. Antipyretic effects may be due to action on the hypothalamus, resulting in increased peripheral blood flow, vasodilation, and subsequent heat dissipation. Inhibition of COX-1 is thought to cause some of the side effects of ibuprofen including GI ulceration. Ibuprofen is administered as a racemic mixture. The R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo. The S-enantiomer is believed to be the more pharmacologically active enantiomer. or We previously showed the non-steroidal anti-inflammatory drug (NSAID) ibuprofen suppresses inflammation and amyloid in the APPsw (Tg2576) Tg2576 transgenic mouse. The mechanism for these effects and the impact on behavior are unknown. We now show ibuprofen’s effects were not mediated by alterations in amyloid precursor protein (APP) expression or oxidative damage (carbonyls). Six months of ibuprofen treatment in Tg+ females caused a decrease in open field behavior (p < 0.05), restoring values similar to Tg- mice. Reduced caspase activation per plaque provided further evidence for a neuroprotective action of ibuprofen. The impact of a shorter 3-month duration ibuprofen trial, beginning at a later age (from 14 to 17 months), was also investigated. Repeated measures ANOVA of Abeta levels (soluble and insoluble) demonstrated a significant ibuprofen treatment effect (p < 0.05). Post-hoc analysis showed that ibuprofen-dependent reductions of both soluble Abeta and Abeta42 were most marked in the entorhinal cortex (p < 0.05). Although interleukin-1beta and insoluble Abeta were more effectively reduced with longer treatment, the magnitude of the effect on soluble Abeta was not dependent on treatment duration. Indications of Ibuprofen IbuprofenTablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions, and symptoms For symptomatic treatment of rheumatoid arthritis, juvenile rheumatoid arthritis, and osteoarthritis. May be used to treat mild to moderate pain and for the management of dysmenorrhea. May be used to reduce fever. Has been used with some success for treating ankylosing spondylitis, gout, and psoriatic arthritis. May reduce pain, fever, and inflammation of pericarditis. May be used IV with opiates to relieve moderate to severe pain. Ibuprofen lysine may be used IV to treat patent ductus arteriosus (PDA) in premature neonates. Treatment of a hemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age Prevention of patent ductus arteriosus in premature neonates of less than 34 weeks of gestational age Polyarthralgia Muscles stiffness in nerve diseases Morning stiffness Multiple joint pain Steroid induce arthritis Osteoarthritis Rheumatoid arthritis Ankylosing spondylitis Gouty arthritis Pain due to especially musculoskeletal system Muscles stiffness in spinal Muscles stiffness in muscle diseases Muscles stiffness in the joint diseases Lumbago Low back pain Pain caused by nonaticular rheumatism Periarthritis of scapulohumeral Ischiadynia Treatment of patent ductus arteriosus Temporarily reduces fever Temporarily relieves minor aches and pains due to a headache the common cold a toothache muscular aches a backache menstrual cramps minor pain of arthritis Therapeutic Indications of Ibuprofen Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase Inhibitors Ibuprofen is used for relief of the pain and inflammation of acute gouty arthritis and acute calcium pyrophosphate deposition disease (pseudogout; chondrocalcinosis articularis; synovitis, crystal-induced). Only immediate-release dosage forms are recommended for relief of acute attacks because of their more rapid onset of action relative to delayed-release or extended-release dosage forms. Ibuprofen is indicated for the relief of mild to moderate pain, especially when anti-inflammatory actions may also be desired, e.g., following dental, obstetric, or orthopedic surgery, and for the relief of musculoskeletal pain due to soft tissue athletic injuries (strains or sprains). Only immediate-release dosage forms are recommended for relief of acute pain because of their more rapid onset of action relative to delayed-release or extended-release dosage forms. Ibuprofen is used in the treatment of psoriatic arthritis. Ibuprofen is indicated for relief of acute or chronic juvenile arthritis. Ibuprofen is indicated for the relief of acute or chronic ankylosing spondylitis. Ibuprofen is indicated for relief of acute or chronic osteoarthritis. Ibuprofen is indicated for the treatment of acute or chronic rheumatoid arthritis. A non-steroidal anti-inflammatory agent that possesses analgesic & antipyretic activity indicated for relief of symptoms of rheumatoid arthritis & osteoarthritis. For the relief of primary dysmenorrhea, ibuprofen therapy should be started with the earliest onset of pain . For the management of juvenile rheumatoid arthritis in the symptomatic treatment of acute and chronic rheumatoid arthritis and osteoarthritis . Contra-Indications of Ibuprofen Active peptic ulcer Acute rhinitis Allergic to thiocolchicoside Asthma Pregnant Concurrent peptic ulcer, or history of ulcer disease Allergy to indometacin, aspirin, or other NSAIDs Patients with nasal polyps reacting with an angioedema to other NSAIDs Children under 2 years of age (with the exception of neonates with patent ductus arteriosus) Severe pre-existing renal and liver damage Caution: pre-existing bone marrow damage (frequent blood cell counts are indicated) Caution: bleeding tendencies of unknown origin ( inhibits platelet aggregation) Caution: Parkinson’s disease, epilepsy, psychotic disorders ( may worsen these conditions) Concurrent with potassium-sparing diuretics Patients who have a patent ductus arteriosus dependent heart defect (such as transposition of the great vessels) Significant hypertension (high blood pressure) Concomitant administration of lithium salts (such as lithium carbonate) Dosage of Ibuprofen Strengths:50 mg; 100 mg; 200 mg; 300 mg; 400 mg; 800 mg; 200 mg;100 mg/5 mL; Dysmenorrhea 200 to 400 mg orally every 4 to 6 hours as needed. Osteoarthritis Initial dose: 400 to 800 mg orally every 6 to 8 hours. Maintenance dose: May be increased to a maximum daily dose of 3200 mg based on patient response and tolerance. Rheumatoid Arthritis Initial dose: 400 to 800 mg orally every 6 to 8 hours. Maintenance dose: May be increased to a maximum daily dose of 3200 mg based on patient response and tolerance. Headache 600 mg orally 90 minutes prior to the initial ECT session Pain 200 to 400 mg orally every 4 to 6 hours as needed. Doses greater than 400 mg have not been proven to provide greater efficacy. IV: (Patients should be well hydrated before IV ibuprofen administration): Pain: 400 to 800 mg intravenously over 30 minutes every 6 hours as needed. Fever 200 to 400 mg orally every 4 to 6 hours as needed. IV: (Patients should be well hydrated before IV ibuprofen administration): Fever: Initial: 400 mg intravenously over 30 minutes Maintenance: 400 mg every 4 to 6 hours or 100 to 200 mg every 4 hours as needed. Pediatric Dose for Fever Greater than 6 months to 12 years 5 mg/kg/dose for temperature less than 102.5 degrees F (39.2 degrees C) orally every 6 to 8 hours as needed. 10 mg/kg/dose for temperature greater than or equal to 102.5 degrees F (39.2 degrees C) orally every 6 to 8 hours as needed. The recommended maximum daily dose is 40 mg/kg. OTC pediatric labeling (analgesic, antipyretic): 6 months to 11 years: 7.5 mg/kg/dose every 6 to 8 hours; Maximum daily dose: 30 mg/kg Pediatric Dose for Pain Infants and Children: 4 to 10 mg/kg orally every 6 to 8 hours as needed. The recommended maximum daily dose is 40 mg/kg. OTC pediatric labeling (analgesic, antipyretic): 6 months to 11 years: 7.5 mg/kg/dose every 6 to 8 hours; Maximum daily dose: 30 mg/kg Pediatric Dose for Rheumatoid Arthritis 6 months to 12 years Usual: 30 to 40 mg/kg/day in 3 to 4 divided doses; start at lower end of dosing range and titrate; patients with milder disease may be treated with 20 mg/kg/day; doses greater than 40 mg/kg/day may increase risk of serious adverse effects; doses greater than 50 mg/kg/day have not been studied and are not recommended. Maximum dose: 2.4 g/day Side Effects of Ibuprofen The most common GI disorders (e.g. dyspepsia, abdominal pain, nausea, vomiting, diarrhoea, flatulence, constipation,, ulcerative stomatitis, ),indigestion, Disturbances of the gut such as diarrhoea, constipation, nausea, vomiting or abdominal pain. Drowsiness and lightheadedness Nausea and vomiting joint pain Nausea and vomiting Severe stomach ache Severe diarrhea Vaginal thrush Skin rash Headache Chest pain Diarrhea or loose stools Difficulty with breathing Dizziness Heartburn Muscle pain More common Abdominal or stomach pain, Chills or fever Headache, Joint or back pain Muscle aching or cramping Muscle pains or stiffness Chest pressure or squeezing pain in chest Excessive sweating feeling of heaviness, pain, warmth and/or swelling in a leg or in the pelvis sudden tingling or coldness in an arm or leg Constipation Diarrhoea Loss of muscle coordination Sleepiness or unusual drowsiness Clumsiness or unsteadiness Drowsiness Rare Anxiety change in vision seizures abnormal or fast heart rate tremors weight loss chest pain or tightness confusion cough Agitation arm, back, or jaw pain blurred vision chest pain or discomfort convulsions extra heartbeats fainting hallucinations headache irritability lightheadedness mood or mental changes muscle pain or cramps muscle spasm or jerking of all extremities muscle pains or stiffness chest pressure or squeezing pain in chest discomfort in arms, shoulders, neck or upper back Drug Interactions of Ibuprofen Ibuprofen may interact with following drugs, supplyments & may change the efficacy of drugs aminoglycoside antibiotics (e.g., amikacin, gentamicin, tobramycin) angiotensin converting enzyme inhibitors (ACEIs; e.g., captopril, enalapril, ramipril) angiotensin receptor blockers (ARBs; e.g., candasartan, irbesartan, losartan) beta-adrenergic blockers (e.g., metoprolol, atenolol) calcium channel blockers (e.g., amlodipine, diltiazem, nifedipine, verapamil) celecoxib cilostazol clopidogrel corticosteroids (e.g., dexamethasone, hydrocortisone, prednisone) cyclosporine diuretics (water pills; e.g., furosemide, hydrochlorothiazide,) 5-ASA medications (e.g. sulfasalazine) glucosamine haloperidol heparin methotrexate multivitamins other non-steroidal anti-inflammatory medications (NSAIDs; e.g., diclofenac, ibuprofen, ketorolac, naproxen) Omega-3 fatty acids pentoxifylline quinolone antibiotics (e.g., ciprofloxacin, ofloxacin) selective serotonin reuptake inhibitors (SSRIs; e.g., citalopram, duloxetine,fluoxetine,paroxetine, sertraline) serotonin/norepinephrine reuptake inhibitors (SNRIs; duloxetine, ) tricyclic antidepressants (e.g., amitriptyline, clomipramine, desipramine, trimipramine) warfarin Pregnancy Category of Ibuprofen FDA pregnancy category: C Pregnancy Animal studies have revealed evidence of increased risk of miscarriage, cardiac malformation, and gastroschisis following use of prostaglandin synthesis inhibitors in early pregnancy. Administration of nonsteroidal anti-inflammatory drugs (NSAIDs) during the third trimester of pregnancy may cause significant adverse effects, including premature closure of the fetal ductus arteriosus, oligohydramnios, fetal renal impairment, pulmonary hypertension, and prolongation of bleeding time. There are no controlled data in human pregnancy. Lactation Not recommended during last trimester of pregnancy. Prior to 30 weeks gestation: Use only if potential benefit justifies the potential risk to the fetus. Avoid use during third trimester as it may cause premature closure of the ductus arteriosus. Tips Take with food or milk if stomach disturbances (such as indigestion) occur with use. See a doctor if these persist. Always use the lowest effective dose for the shortest duration consistent with the condition being treated. If you are taking ibuprofen and find it is not working very well for you, you may like to try a different NSAID. Response to different NSAIDs can vary so switching types (for example, from ibuprofen to naproxen) may improve response. See a doctor immediately if you experience any difficulty with breathing, unexplained sickness or fatigue, loss of appetite, vision changes, fluid retention or abnormal bleeding. NSAIDs should not be used in the last 3 months of pregnancy; ask your doctor before using any medication during pregnancy. Avoid ibuprofen if you have a history of asthma or hives due to aspirin use or other NSAIDs, like naproxen. Do not use this medicine if you have just had heart bypass surgery (also called coronary artery bypass graft, or CABG). References DrugBank http://www.drugbank.ca/drugs/DB01050 http://www.drugbank.ca/drugs/DB01050#transporters http://www.drugbank.ca/drugs/DB01050#carriers http://www.drugbank.ca/drugs/DB01050#targets http://www.drugbank.ca/drugs/DB01050#enzymes EPA DSStox https://comptox.epa.gov/dashboard/dsstoxdb/results?search=DTXSID5020732 European Chemicals Agency (ECHA) https://echa.europa.eu/substance-information/-/substanceinfo/100.036.152 https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/133658 https://www.webmd.com/drugs/2/drug-5166-9368/ibuprofen-oral/ibuprofen-oral/details/list-contraindications Human Metabolome Database (HMDB) http://www.hmdb.ca/metabolites/HMDB0001925 ClinicalTrials.gov https://clinicaltrials.gov/ DailyMed https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ADVIL+ALLERGY+AND+CONGESTION+RELIEF https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=DUEXIS https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=HYDROCODONE+BITARTRATE+AND+IBUPROFEN https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ADVIL+PM https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=IBUPROFEN https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ADVIL+COLD+AND+SINUS LiverTox https://livertox.nlm.nih.gov/Ibuprofen.htm NCIT https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C561 EU Community Register of Medicinal Products https://ec.europa.eu/health/documents/community-register/html/h284.htm https://ec.europa.eu/health/documents/community-register/html/o027.htm https://ec.europa.eu/health/documents/community-register/html/o020.htm HSDB https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+@rel+15687-27-1 WHO ATC https://www.whocc.no/atc/ https://www.whocc.no/atc_ddd_index/ NITE-CMC http://www.safe.nite.go.jp/english/ghs/11-mhlw-0122e.html FDA Medication Guides https://www.fda.gov/downloads/Drugs/DrugSafety/ucm088647.pdf FDA Orange Book https://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm SpectraBase https://spectrabase.com/compound/GmeBdweaJfU#8qw2PVACnRU https://spectrabase.com/compound/GmeBdweaJfU#FMt1Nmq0R7z https://spectrabase.com/compound/GmeBdweaJfU#6GyKGlmUgyU https://spectrabase.com/compound/GmeBdweaJfU#HJcucTQLRmK https://spectrabase.com/compound/GmeBdweaJfU#6EyTgJSh75l https://spectrabase.com/compound/GmeBdweaJfU#6tzhwUAiQN0 https://spectrabase.com/compound/GmeBdweaJfU#9t27TQ2RTkK https://spectrabase.com/compound/GmeBdweaJfU#Fv3A4LN4wfc https://spectrabase.com/compound/GmeBdweaJfU#LHFLJGK6rx https://spectrabase.com/compound/GmeBdweaJfU#7EIk8i47TDx MassBank of North America (MoNA) http://mona.fiehnlab.ucdavis.edu/spectra/browse?inchikey=HEFNNWSXXWATRW-UHFFFAOYSA-N NIST http://www.nist.gov/srd/nist1a.cfm PubMed Health http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010649/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0000915/ http://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0010648/ Springer Nature . Read more … https://pubchem.ncbi.nlm.nih.gov/substance/341157013 Wikipedia https://www.drugs.com/ibuprofen.html https://en.wikipedia.org/wiki/Ibuprofen https://pubchem.ncbi.nlm.nih.gov Show More